BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21626717)

  • 1. Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.
    Hameed S; Jaffé A; Verge CF
    Pediatr Pulmonol; 2011 Aug; 46(8):747-60. PubMed ID: 21626717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the detection and management of cystic fibrosis related diabetes.
    Hameed S; Jaffé A; Verge CF
    Curr Opin Pediatr; 2015 Aug; 27(4):525-33. PubMed ID: 26087430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
    Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cystic fibrosis-related diabetes: a systematic review.
    Waugh N; Royle P; Craigie I; Ho V; Pandit L; Ewings P; Adler A; Helms P; Sheldon C
    Health Technol Assess; 2012; 16(24):iii-iv, 1-179. PubMed ID: 22572153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased detection of cystic-fibrosis-related diabetes in Australia.
    Rana M; Munns CF; Selvadurai HC; Simonds S; Cooper PJ; Woodhead HJ; Hameed S; Verge CF; Lafferty AR; Crock PA; Craig ME
    Arch Dis Child; 2011 Sep; 96(9):823-6. PubMed ID: 21653750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
    Moheet A; Moran A
    J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
    Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
    Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does β-Cell Autoimmunity Play a Role in Cystic Fibrosis-Related Diabetes? Analysis Based on the German/Austrian Diabetes Patienten Verlaufsdokumentation Registry.
    Konrad K; Kapellen T; Lilienthal E; Prinz N; Bauer M; Thon A; Rietschel E; Wiemann D; Holl RW;
    Diabetes Care; 2016 Aug; 39(8):1338-44. PubMed ID: 27271187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing cystic fibrosis-related diabetes: current methods and challenges.
    Prentice B; Hameed S; Verge CF; Ooi CY; Jaffe A; Widger J
    Expert Rev Respir Med; 2016 Jul; 10(7):799-811. PubMed ID: 27268400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic Fibrosis-Related Diabetes in Children: An Update.
    Kim RJ
    Pediatr Ann; 2016 Sep; 45(9):e321-6. PubMed ID: 27622916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
    Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
    Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment.
    Alves C; Della-Manna T; Albuquerque CTM
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):835-843. PubMed ID: 32651985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.